Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma 31/03/2014

Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma.
If you are interested in taking part in a clinical trial, please call us at 935 950 155 and we will assess whether you are eligible. Further information on trials at research projects
Author
Dr Marta Pazos, médecin
Inscrite à l'ordre des médecins de Barcelone, sous le numéro 38658
Ophtalmologiste
Spécialiste du glaucome